1. A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs). (2nd September 2018) Authors: Larson, Christopher; Oronsky, Bryan; Varner, Gina; Caroen, Scott; Burbano, Erica; Insel, Elisa; Hedjran, Farah; Carter, Corey A.; Reid, Tony R. Journal: Oncoimmunology Issue: Volume 7:Number 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet. (6th March 2018) Authors: Cottrill, Hope; Cason, Stephanie; Caroen, Scott; Oronsky, Bryan; Donaldson, Elvis Journal: Journal of investigative medicine high impact case reports Issue: Volume 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CMET-46. INITIAL CLINICAL AND ADVANCED IMAGING OUTCOMES FROM A MULTI-INSTITUTIONAL PHASE I DOSE-ESCALATION TRIAL OF RRX-001 PLUS WHOLE BRAIN RADIATION FOR PATIENTS WITH BRAIN METASTASES. (5th November 2018) Authors: Kim, Michelle; Parmar, Hemant; Aryal, Madhava; Schipper, Matthew; Devasia, Theresa; Kesari, Santosh; Morikawa, Aki; Spratt, Daniel; Junck, Larry; Hayman, James; Lawrence, Theodore; Tsien, Christina; Aiken, Robert; Goyal, Sharad; Knox, Susan; Caroen, Scott; Carter, Corey; Oronsky, Bryan; Cao, Yue;... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply. (December 2022) Authors: Oronsky, Bryan; Larson, Christopher; Caroen, Scott; Reid, Tony R. Journal: International journal of infectious diseases Issue: Volume 125(2022) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nucleocapsid as a next-generation COVID-19 vaccine candidate. (September 2022) Authors: Oronsky, Bryan; Larson, Christopher; Caroen, Scott; Hedjran, Farah; Sanchez, Ana; Prokopenko, Elena; Reid, Tony Journal: International journal of infectious diseases Issue: Volume 122(2022) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC. (2016) Authors: Carter, Corey A.; Oronsky, Bryan; Caroen, Scott; Scicinski, Jan; Cabrales, Pedro; Degesys, Aiste; Brzezniak, Christina Journal: Respiratory medicine case reports Issue: Volume 18(2016) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rationale and necessity for delivery of RRx-001, a Myc and CD47 antagonist, by intravenous blood mix. (2nd June 2020) Authors: Caroen, Scott; Oronsky, Bryan; Carter, Corey; Lybeck, Michelle; Oronsky, Arnold; Reid, Tony Journal: Expert opinion on drug delivery Issue: Volume 17:Number 6(2020) Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Results from a biomarker study to accompany a phase II trial of RRx-001 with reintroduced platinum-based chemotherapy in relapsed small cell carcinoma. (1st February 2021) Authors: Lee, Min-Jung; Tomita, Yusuke; Yuno, Akira; Lee, Sunmin; Abrouk, Nacer E.; Oronsky, Bryan; Caroen, Scott; Trepel, Jane B. Journal: Expert opinion on investigational drugs Issue: Volume 30:Number 2(2021) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. RRx-001 and the "Right stuff": Protection and treatment in outer space. (November 2022) Authors: Oronsky, Bryan; Caroen, Scott; Abrouk, Nacer; Reid, Tony R. Journal: Life sciences in space research Issue: Volume 35(2022) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. RRx-001, a downregulator of the CD47- SIRPα checkpoint pathway, does not cause anemia or thrombocytopenia. (3rd April 2021) Authors: Oronsky, Bryan; Cabrales, Pedro; Caroen, Scott; Guo, Xiaoning; Scribner, Curtis; Oronsky, Arnold; Reid, Tony R. Journal: Expert opinion on drug metabolism and toxicology Issue: Volume 17:Number 4(2021) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗